Navigation Links
STC.UNM Signs License Option Agreement With GeneThera for E. coli O157:H7 Vaccine
Date:10/27/2008

er sources with these potentially deadly microbes. The overall result is safer foods, reduced mortality and illness of consumers and savings from costly meat recalls. The bacteria used to create the vaccine are easily cultured and harmless.

Commenting on the news, GeneThera Chairman Dr. Tony Milici, M.D., Ph.D., stated, "We are very excited about the signing of this agreement with STC.UNM. It is our intention to initiate clinical trials for the E. coli vaccine in the near future. Our goal is to take the vaccine to market as soon as possible. E. coli infection represents a great threat for the food industry and it is no longer limited to beef as recent episodes have shown. Every year more than 70 people die from E. coli infection. Children in particular are more vulnerable to this infection. A recent study estimated the annual cost of E. coli O157:H7 illnesses to be $405 million (in 2003 dollars), which included $370 million for premature deaths, $30 million for medical care, and $5 million for lost productivity."

Dr. Milici went on to say that "the CDC has estimated that 85% of E. coli O157:H7 infections are food borne in origin. In fact, consumption of any food or beverage that becomes contaminated by animal (especially cattle) manure can result in contracting the disease."

The vaccine has already passed the initial animal trials, and is on the fast track for phase 2 clinical trials according to Dr. Milici.

STC.UNM President & CEO, Lisa Kuuttila, stated that "STC looks forward to the next stage of development enabled by this agreement. GeneThera will be conducting an important trial of the vaccine."

GeneThera hopes to complete clinical trials within the next 9-12 months. That could mean a viable vaccine to help prevent E. coli infections could be available for worldwide distribution to all commercial cattle producers in the very near future.

ABOUT GENETHERA, INC.

GeneThera, Inc., is a molecular biotechnology company
'/>"/>

SOURCE GeneThera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NC (PRWEB) November 25, 2014 ... Intensity Focused Ultrasound (HIFU) devices, recently participated in ... Small Renal Mass 360° .” Key opinion leaders ... therapeutic advances related to small renal masses while ... about different ablative technologies in hands-on labs. Attendees ...
(Date:11/26/2014)... 25, 2014 The Pittcon marketing department ... conference and exposition mobile app, Pittcon ... in the App Store for iOS and Android devices ... tool before, during and after the event. It acts ... exhibiting companies, technical sessions, Conferee Networking sessions and short ...
(Date:11/26/2014)... SoundConnect , an award winning ... announce that Darren Suders has joined the team as ... drive the partner program through innovative offerings, ... , Darren brings more than 10-years of channel telecommunication ... channel operations, from policy development, to partner education and ...
(Date:11/26/2014)... TOKYO , 25 novembre 2014 Theravalues ... Super sur le marché européen au salon Hi ... Amsterdam ). Curcumine la ... une technologie amorphe (non-cristalline) à des ingrédients approuvés ... est un pigment jaune présent dans la racine ...
Breaking Biology Technology:SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3Pittcon Releases 2015 Mobile App 2SoundConnect Appoints Director of Channel Development & Sales 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3
... , NORTH BILLERICA, Mass., Sept. 9 ... development of instruments for assessing cellular bioenergetics, today announced it ... power of the XF Extracellular Flux Analyzer in revealing the ... glycolysis in cancer cells. The data will appear in ...
... CLEVELAND, Ohio and DENVER, Colorado, September 9 ... training,products for clinical professionals, today announced the appointment of ... eLearning and Content,business. , Mr. ... building innovative information products and services for a variety ...
... JERUSALEM, September 9 Oramed Pharmaceticals,Inc. (OTCBB: ORMP.OB), a ... has received approval from the Institutional Review Board (IRB),to ... This approval was,granted after successful pre-clinical results were reported. ... University Medical Center in,Jerusalem. , ...
Cached Biology Technology:Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference 2Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 3
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... created a continuous chemical process that produces useful crude oil ... verdant green paste with the consistency of pea soup. ... Northwest National Laboratory was reported recently in the journal ... licensed the technology and is working with an industrial partner ...
... that people who drink moderate amounts of alcohol actually have ... and have better cardiovascular function that those who don,t drink ... & Science University adds a fascinating twist: moderate drinking may ... infection. The research, published Dec. 17 in the journal ...
... upward of 170,000 people worldwide this year, but bladder cancer ... fatal the disease must metastasize to faraway sites. The question ... eventually become the more dangerous, muscle-invasive (MI) form of the ... from the start? A University of Colorado Cancer ...
Cached Biology News:Algae to crude oil: Million-year natural process takes minutes in the lab 2Algae to crude oil: Million-year natural process takes minutes in the lab 3Study: Moderate alcohol consumption boosts body's immune system 2Study: Moderate alcohol consumption boosts body's immune system 3Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells 2
... deparaffinize and perform Heat Induced Antigen Retrieval ... mounted on glass microscope slides. Deparffinization is ... high temperature used in HIER (over 90degrees ... by detergent. Formaldehyde fixation impairs or totally ...
...
...
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Biology Products: